Citation171,Citation172 Additionally, studies on NRC-03 and NRC-07 (two AMPs from the pleurocidin AMP family) showed that the 50% effective concentration (EC 50 ) of cisplatin on tumor cells could be significantly reduced when used in combination with NRC-03 or NRC-07, that is, the cytotoxicity of cisplatin was increased
Individuals with Wilson's disease or copper metabolism disorders should avoid GHK-CU entirely
For convenience and needle aversion : Oral GHK-Cu is the easiest option, but understand that systemic benefits will be significantly limited by poor bioavailability
2020;192:E87591
If IGF-1 remains below the mid-reference range, the dose may be increased to the 500 mcg ceiling
How We Share Information We share information only as needed to operate our practice for example, with service providers who host our website, schedule appointments, or process communications on our behalf, under contracts that require them to protect your information